ILiAD Biotechnologies
Updated: March 04, 2026
CEO - Keith Rubin
Country: USA | Funding: $180M (+)
Founded: 2012
Website: https://iliadbio.com/
ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
Founded: 2012
Website: https://iliadbio.com/
ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
